Skip to content

A clinical study on the effectiveness and safety of Ciprofol injection for induction of general anesthesia in elderly patients undergoing laparoscopic cholecystectomy

A clinical study on the effectiveness and safety of Ciprofol injection for induction of general anesthesia in elderly patients undergoing laparoscopic cholecystectomy

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044740
Enrollment
Unknown
Registered
2021-03-26
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly patients

Interventions

control group 1:Induction of anesthesia with propofol injection
control group 2:Induction of anesthesia with etomidate injection

Sponsors

Changshu No.2 People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. 65 to 70 years old, no gender limit; 2. American Anesthesiologists (ASA) III; 3. Elderly laparoscopic cholecystectomy patients who need tracheal intubation for elective surgery; 4. Body mass index (BMI) >= 18 and = 10 and = 95% when breathing air; systolic blood pressure (SBP) >= 90mmHg and = 60mmHg and = 55 and <= 100 beats/min; 6. Able to understand the research process and methods, and voluntarily participate in this research.

Exclusion criteria

Exclusion criteria: 1. Those who have general anesthesia contraindications or have a history of anesthesia accidents; 2. Those who are known or suspected to be allergic or contraindicated to propofol injection, cyclopofol injection excipients, benzodiazepines, opioids, muscle relaxants, etc.; 3. Patients with craniocerebral loss, intracranial hypertension, stroke, unstable angina, and myocardial infarction; 4. Respiratory insufficiency, obstructive pulmonary disease, difficult airway, or difficulty in tracheal intubation (modified Markov score is III or IV); 5. Uncontrolled diabetes or hypertension; 6. Severe liver dysfunction or severe renal insufficiency; 7. History of alcohol abuse or drug dependence; 8. Abuse or long-term use of narcotic, sedative, and analgesic drugs; 8. Those who have a history of mental illness; 10. Those who have participated in any drug clinical trial within 1 month before screening; 11. Pregnant and lactating women; fertile women or men who are unwilling to use contraception during the entire trial period; subjects (including male subjects) who have pregnancy plans within 1 month after the trial; 12. The investigator believes that there are any other subjects who are not suitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Anesthesia induction success rate;

Countries

China

Contacts

Public ContactWang Meifang

Changshu No.2 People's Hospital

2003wmf@163.com+86 13812805011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026